Renal anemia control in Lithuania: Influence of local conditions and local guidelines

The Scientific World Journal

Volumn 2013, Issue , 2013, Pages

  Ziginskiene, Edita ^a   Kuzminskis, Vytautas ^a   Petruliene, Kristina ^a   Vaiciuniene, Ruta ^a   Stankuviene, Asta ^a   Bumblyte, Inga Arune ^a  

^a LITHUANIAN UNIVERSITY OF HEALTH SCIENCES   (Lithuania)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN; IRON;

ANEMIA; ARTICLE; BLOOD; FEMALE; HUMAN; KIDNEY DISEASE; LITHUANIA; MALE; METABOLISM; QUESTIONNAIRE; RENAL REPLACEMENT THERAPY;

ANEMIA; FEMALE; HEMOGLOBINS; HUMANS; IRON; KIDNEY DISEASES; LITHUANIA; MALE; QUESTIONNAIRES; RENAL DIALYSIS;

EID: 84893821380     PISSN: None     EISSN: 1537744X     Source Type: Journal    
DOI: 10.1155/2013/260915     Document Type: Article

References (21)

1. Ziginskiene E., Kuzminskis V., Bumblyte I. A., Relationship between lethality of hemodialysis patients, erythropoietin dosage for renal anemia treatment and hemodialysis quality. Medicina 2003 39 119 125 2-s2.0-41049091198
2. NKF-K/DOQI, NKF-K/DOQI clinical practice guidelines and glinical practice recommendations for anemia in chronic kidney disease: 2007 update of hemoglobin target. American Journal of Kidney Diseases 2007 50 474
3. ERBP, European best practice guidelines. Nephrology Dialysis Transplantation 2009 24 4 1267 1274
4. KDIGO, KDIGO clinical practice guidelines for anemia in chronic kidney disease. Kidney International Supplements 2012 2 283 329
5. McFarlane P. A., Pisoni R. L., Eichleay M. A., Wald R., Port F. K., Mendelssohn D., International trends in erythropoietin use and hemoglobin levels in hemodialysis patients. Kidney International 2010 78 2 215 223 2-s2.0-77954243266 10.1038/ki.2010.108
6. Gejyo F., Saito A., Akizawa T., Akiba T., Sakai T., Suzuki M., Nishi S., Tsubakihara Y., Hirakata H., Bessho M., Japanese society for dialysis therapy guidelines for renal anemia in chronic hemodialysis patients. Therapeutic Apheresis and Dialysis 2004 8 6 443 459 2-s2.0-13844254456
7. DOPPS Annual Report 2010. http://www.dopps.org/annualreport/
8. Rozen-Zvi B., Gafter-Gvili A., Paul M., Leibovici L., Shpilberg O., Gafter U., Intravenous versus oral iron supplementation for the treatment of anemia in CKD: systematic review and meta-analysis. American Journal of Kidney Diseases 2008 52 5 897 906 2-s2.0-54349090164 10.1053/j.ajkd.2008.05.033
9. Li H., Wang S.-X., Intravenous iron sucrose in Chinese hemodialysis patients with renal anemia. Blood Purification 2008 26 2 151 156 2-s2.0-40949099590 10.1159/000113529 (Pubitemid 351416698)
10. Xia H., Ebben J., Ma J. Z., Collins A. J., Hematocrit levels and hospitalization risks in hemodialysis patients. Journal of the American Society of Nephrology 1999 10 6 1309 1316 2-s2.0-0032991310 (Pubitemid 29246997)
11. Locatelli F., Pisoni R. L., Combe C., Bommer J., Andreucci V. E., Piera L., Greenwood R., Feldman H. I., Port F. K., Held P. J., Anaemia in haemodialysis patients of five European countries: association with morbidity and mortality in the Dialysis Outcomes and Practice Patterns study (DOPPS). Nephrology Dialysis Transplantation 2004 19 1 121 132 2-s2.0-2942755881 10.1093/ndt/gfh314 (Pubitemid 38786778)
12. Furuland H., Linde T., Ahlmén J., Christensson A., Strömbom U., Danielson B. G., A randomized controlled trial of haemoglobin normalization with epoetin alfa in pre-dialysis and dialysis patients. Nephrology Dialysis Transplantation 2003 18 2 353 361 2-s2.0-0037317068 10.1093/ndt/18.2.353 (Pubitemid 36181688)
13. Jurkovitz C. T., Abramson J. L., Vaccarino L. V., Weintraub W. S., McClellan W. M., Association of High Serum Creatinine and Anemia Increases the risk of coronary events: results from the prospective community-based Atherosclerosis Risk in Communities (ARIC) study. Journal of the American Society of Nephrology 2003 14 11 2919 2925 2-s2.0-0142213905 10.1097/01.ASN.0000092138.65211.71 (Pubitemid 37305654)
14. McClellan W. M., Flanders W. D., Langston R. D., Jurkovitz C., Presley R., Anemia and renal insufficiency are independent risk factors for death among patients with congestive heart failure admitted to community hospitals: a population-based study. Journal of the American Society of Nephrology 2002 13 7 1928 1936 2-s2.0-0036296978 10.1097/01.ASN.0000018409.45834.FA (Pubitemid 34700619)
15. Ito S., Murai S., Sugiura M., Yoshida T., Fukutomi T., Predictors of congestive heart failure in patients on maintenance hemodialysis. Circulation Journal 2007 71 9 1424 1429 2-s2.0-34548513991 10.1253/circj.71.1424 (Pubitemid 47378444)
16. Kramann R., Floege J., Ketteler M., Marx N., Branderburg V. M., Medical options to fight mortality in end stage renal disease: a review of the literature. Nephrology Dialysis Transplantation 2012 27 12 4298 4307
17. Eckardt K.-U., Kim J., Kronenberg F., Aljama P., Anker S. D., Canaud B., Molemans B., Stenvinkel P., Schernthaner G., Ireland E., Fouqueray B., Macdougall I. C., Hemoglobin variability does not predict mortality in european hemodialysis patients. Journal of the American Society of Nephrology 2010 21 10 1765 1775 2-s2.0-77957882690 10.1681/ASN.2009101017
18. Gilbertson D. T., Peng Y., Bradbury B., Ebben J. P., Collins A. J., Hemoglobin loevel variability: Anemia management among variability groups. American Journal of Nephrology 2009 30 6 491 498 2-s2.0-70349417003 10.1159/000243565
19. Gilbertson D. T., Ebben J. P., Foley R. N., Weinhandl E. D., Bradbury B. D., Collins A. J., Hemoglobin level variability: associations with mortality. Clinical Journal of the American Society of Nephrology 2008 3 1 133 138 2-s2.0-38749142226 10.2215/CJN.01610407
20. Ebben J. P., Gilbertson D. T., Foley R. N., Collins A. J., Hemoglobin level variability: associations with comorbidity, intercurrent events, and hospitalizations. Clinical Journal of the American Society of Nephrology 2006 1 6 1205 1210 2-s2.0-34547414592 10.2215/CJN.01110306
21. Yang W., Israni R. K., Brunelli S. M., Joffe M. M., Fishbane S., Feldman H. I., Hemoglobin variability and mortality in ESRD. Journal of the American Society of Nephrology 2007 18 12 3164 3170 2-s2.0-36849005089 10.1681/ASN.2007010058 (Pubitemid 350223976)